5AM Ventures, founded in 2002, is a venture capital fund specializing in early-stage biotech and health tech companies. They focus on life science innovations, including biopharmaceuticals, therapeutic areas, and platform technologies. Notable investments include Nouscom. They seek unique technologies, corporate spin-offs, and market-ready products, typically investing at the Series B stage.
